[HTML][HTML] Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?
HV Heemers - International journal of biological sciences, 2014 - ncbi.nlm.nih.gov
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
[PDF][PDF] Targeting Androgen Receptor Action for Prostate Cancer Treatment: Does the Post-Receptor Level Provide Novel Opportunities?
HV Heemers - International Journal of Biological Sciences, 2014 - researchgate.net
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
[PDF][PDF] Targeting Androgen Receptor Action for Prostate Cancer Treatment: Does the Post-Receptor Level Provide Novel Opportunities?
HV Heemers - International Journal of Biological Sciences, 2014 - Citeseer
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
[PDF][PDF] Targeting Androgen Receptor Action for Prostate Cancer Treatment: Does the Post-Receptor Level Provide Novel Opportunities?
HV Heemers - International Journal of Biological Sciences, 2014 - pdfs.semanticscholar.org
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?
HV Heemers - International journal of biological sciences, 2014 - pubmed.ncbi.nlm.nih.gov
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
[HTML][HTML] Targeting Androgen Receptor Action for Prostate Cancer Treatment: Does the Post-Receptor Level Provide Novel Opportunities?
HV Heemers - International Journal of Biological Sciences, 2014 - ijbs.com
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?
HV Heemers - International Journal of Biological Sciences, 2014 - europepmc.org
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
Targeting Androgen Receptor Action for Prostate Cancer Treatment: Does the Post-Receptor Level Provide Novel Opportunities?
HV Heemers - International Journal of Biological Sciences, 2014 - ijbs.com
The standard of care for patients who suffer from non-organ confined prostate cancer (CaP)
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …
is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen …